Breaking News, Promotions & Moves

Abzena Names Dr. Jeffrey Mocny as Scientific Lead

Mocny has extensive experience with biopharmaceutical regulations.

Author Image

By: Charlie Sternberg

Associate Editor

Abzena, a Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has appointed Jeffrey Mocny, Ph.D. as scientific lead.   Reporting to Abzena’s head of Scientific Leaders, Dr. Petra Dieterich, Mocny will use his extensive experience with biopharmaceutical regulations to support Abzena’s successful drug development and manufacturing operations, ultimately assisting in getting more successful treatments ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters